Omega-3 fatty acids and risk of cognitive decline in the elderly: a meta-analysis of randomized controlled trials (Q35646725)

9 August 2017

0 references

Omega-3 fatty acids and risk of cognitive decline in the elderly: a meta-analysis of randomized controlled trials (English)

1 reference

9 August 2017

0 references

Xiao-Wei Zhang

1

1 reference

9 August 2017

Wen-Shang Hou

series ordinal

2

1 reference

9 August 2017

Min Li

series ordinal

3

1 reference

9 August 2017

Zhen-Yu Tang

series ordinal

4

1 reference

9 August 2017

30 May 2015

1 reference

Aging Clinical and Experimental Research

9 August 2017

1 reference

9 August 2017

28

1 reference

9 August 2017

1

1 reference

9 August 2017

165-166

1 reference

https://scigraph.springernature.com/pub.10.1007/s40520-015-0381-9

9 August 2017

0 references

cites work

Fatty acids, lipid metabolism and Alzheimer pathology.

1 reference

https://api.crossref.org/works/10.1007%2FS40520-015-0381-9

Nutrition in brain development and aging: role of essential fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40520-015-0381-9

Effects of a diet integration with an oily emulsion of DHA-phospholipids containing melatonin and tryptophan in elderly patients suffering from mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40520-015-0381-9

Effects of n-3 fatty acids on cognitive decline: a randomized, double-blind, placebo-controlled trial in stable myocardial infarction patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40520-015-0381-9

Docosahexaenoic acid-concentrated fish oil supplementation in subjects with mild cognitive impairment (MCI): a 12-month randomised, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40520-015-0381-9

Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40520-015-0381-9

The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40520-015-0381-9

Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40520-015-0381-9

Effect of 2-y n-3 long-chain polyunsaturated fatty acid supplementation on cognitive function in older people: a randomized, double-blind, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40520-015-0381-9

The effects of 90-day supplementation with the omega-3 essential fatty acid docosahexaenoic acid (DHA) on cognitive function and visual acuity in a healthy aging population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40520-015-0381-9

Omega-3 fatty acids reverse age-related decreases in nuclear receptors and increase neurogenesis in old rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40520-015-0381-9

Omega-3 polyunsaturated fatty acids increase the neurite outgrowth of rat sensory neurones throughout development and in aged animals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40520-015-0381-9

n-3 polyunsaturated fatty acids supplementation enhances hippocampal functionality in aged mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40520-015-0381-9

10.1007/S40520-015-0381-9

21 January 2018

Identifiers

DOI

1 reference

9 August 2017

1 reference